Why wait? FDA gives ear­ly OK to Mer­ck’s Keytru­da for front­line lung can­cer

That didn’t take long.

Two weeks af­ter Mer­ck $MRK made a tri­umphant vic­to­ry march against Bris­tol-My­ers Squibb on the front­line non-small cell lung can­cer front …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.